Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation
1 other identifier
interventional
78
1 country
1
Brief Summary
This is a parallel group pilot study comparing the efficacy green kiwifruit, prunes or psyllium on abdominal and bowel related symptoms in US patients with chronic constipation patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2018
CompletedStudy Start
First participant enrolled
June 11, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2019
CompletedOctober 17, 2019
October 1, 2019
1.3 years
June 11, 2018
October 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
: Change in complete spontaneous bowel movement (CSBM)
Complete spontaneous bowel movement will be recorded. This will be compared to the baseline, run-in periods, and follow-up period.
8 weeks
Secondary Outcomes (6)
Change in SBM (spontaneous bowel movements)
8 weeks
stool consistency
8 weeks
straining
8 weeks
abdominal pain
8 weeks
abdominal discomfort
8 weeks
- +1 more secondary outcomes
Study Arms (3)
Kiwifruit
ACTIVE COMPARATORTreating chronic constipation with 2 kiwifruit (6g fiber) per day
Psyllium fiber
ACTIVE COMPARATORTreating chronic constipation with 24g psyllium fiber (6g fiber) per day
Prune
ACTIVE COMPARATORTreating chronic constipation with 100g dried plums (6g fiber) per day
Interventions
The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive kiwifruit (2 green kiwifruit per day for the 4 week intervention period.
The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive psyllium fiber (24 g/day, fiber=6g/day) for the 4 week intervention period.
The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive prunes/dried plums (100g, fiber=6 g/day) for the 4 week intervention period.
Eligibility Criteria
You may qualify if:
- \. Presence of functional constipation according to modified ROME IV diagnostic criteria\*5b i. Must include two or more of the following:
- Straining more than 25% of defecations
- Lumpy or hard stools more than 25% of defecations
- Sensation of incomplete evacuation more than 25% of defecations
- Sensation of anorectal obstruction/blockage more than 25% of defecations
- Manual manoeuvres to facilitate more than 25% of defecations (e.g. digital evacuation, support of pelvic floor)
- Fewer than three defecations per week ii. Loose stools are rarely present without the use of laxatives \* Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis For the purposes of this study, patients with abdominal pain will be included, but patients with severe pain (defined as average daily abdominal pain score of 7 or higher during the screening period) will be excluded. Patients with an appropriate level of GI symptoms despite taking stable doses (\>3 months) of SSRI's, tricyclics or SNRIs will be allowed to enroll.
You may not qualify if:
- Potential participants will be excluded if they have alarm features (GI bleeding, weight loss, unexplained iron deficiency anaemia, significant family history of colorectal cancer or IBD), anal fissures, significant chronic diseases (cardiovascular, cancer, renal failure, inflammatory bowel disease), previous gastrointestinal surgery (except appendectomy or cholecystectomy), neurological diseases (e.g. multiple sclerosis, spinal cord injury, CVA).
- Patients taking opiates will not be eligible to participate. Women who are pregnant, breastfeeding or planning a pregnancy in the 2 months post selection (trial period) will be excluded.
- As above, patients with severe IBS symptoms will be excluded (defined as average daily abdominal pain score of 7 or higher during the screening period).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (2)
Chey SW, Chey WD, Jackson K, Eswaran S. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. Am J Gastroenterol. 2021 Jun 1;116(6):1304-1312. doi: 10.14309/ajg.0000000000001149.
PMID: 34074830DERIVEDDimidi E, Staudacher HM. Could a kiwifruit a day keep the doctor away? Lancet Gastroenterol Hepatol. 2020 Jul;5(7):648. doi: 10.1016/S2468-1253(20)30163-1. No abstract available.
PMID: 32553145DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shanti Eswaran, MD
Department of Internal Medicine, Division of Gastroenterology, University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
June 11, 2018
First Posted
June 26, 2018
Study Start
June 11, 2018
Primary Completion
October 10, 2019
Study Completion
October 10, 2019
Last Updated
October 17, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share